SCHEMBL6835665

SCHEMBL6835665

O=C(CCC(=O)Oc1c[nH]c2ccccc12)Oc1c[nH]c2ccccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC22A6 Q4U2R8 2/20 0.68
MAPT P10636 4/20 0.51
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
LMNA P02545 2/20 0.50
PBRM1 Q86U86 1/20 0.50
ALDH1A1 P00352 1/20 0.50
KDM4E B2RXH2 2/20 0.49
GABRA1 P14867 1/20 0.49
GABRB2 P47870 1/20 0.49
APAF1 O14727 1/20 0.49
POLB P06746 1/20 0.49
RECQL P46063 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
MPO P05164 1/20 0.49
TSHR P16473 1/20 0.49
BLM P54132 1/20 0.49
PMP22 Q01453 1/20 0.49
HIF1A Q16665 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148210 0.92 SLC22A6 (0.67) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL27663677 0.92 SLC22A6 (0.62) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL28021733 0.91 SLC22A6 (0.65) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL17536618 0.91 SLC22A6 (0.65) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL28215558 0.91 SLC22A6 (0.65) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL1714417 0.90 SLC22A6 (0.68) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL3446433 0.88 SLC22A6 (0.66) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL14838019 0.88 SLC22A6 (0.61) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL10599504 0.88 SLC22A6 (0.61) SLC22A6MAPTMEN1KMT2ASMN1; SMN2
SCHEMBL27718387 0.88 SLC22A6 (0.57) SLC22A6MAPTMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102702175-A Preparation method of indole-3-succinimide UNIV DONGHUA 2012-10-03 CN disclosed
US-6753297-B2 TREATING A PLANT WITH AN INDOLE-3-CARBOXYLIC ACID COMPOUND FOR PROMOTING GROWTH IN PLANTS HAMMER CHARLES (US) 2004-06-22 US disclosed
US-20030158043-A1 Use of indole-3-succinic acid as auxin HAMMER CHARLES (US) 2003-08-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030158043-A1 Use of indole-3-succinic acid as auxin SPIN3, SUCNR1, SUMO3 SLC22A6 1105/4885MAPT 2604/4885MEN1 4053/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.